Jagsonpal Pharmaceuticals share news, announcements and annual reports

NSE: JAGSNPHARMBSE: 507789Pharmaceuticals & BiotechnologySmall Cap

Jagsonpal Pharmaceuticals Limited · Face value ₹2 · Listed May 1987 on BSE, Mar 2000 on NSE

₹216.09₹5.85 (2.64%)BSE ₹216.90

Share price at the NSE close on 30 Oct 2026. Previous close ₹221.94.

30 Oct: open ₹222.00, high ₹226.64, low ₹212.58

52-week range of traded prices to 30 Oct 2026

₹155.00Low, 22 Jan 2026₹264.50High, 30 Jun 2026

Market cap: ₹1,427 Cr1,360th largest listed
P/E: 31.38
P/B: 5.93
Dividend yield: 1.85%
ROE: 18.3%
ROCE: 21.7%
Debt to equity: 0.00
Volume, NSE: 71,54749.3% delivered

Jagsonpal Pharmaceuticals share news and announcements

550 announcements, routine notices left out, newest first. Page 9 of 11.

Oct 2017
- 3 Oct · Demise
  Demise of Mr Govind Deo, Non- Executive Independent Director of the company on September 30, 2017.
Sep 2017
Aug 2017
- 14 Aug · Board meeting
  Outcome of Board Meeting held on August 14, 2017.JPL/Stock-Corr-2013 August 14th, 2017 The Manager - Listing The National Stock Exchange of India Ltd.Exchange Plaza, Bandra-Kurla ComplexBandra (E), Mumbai - 400 051 The Manager - Listing The Bombay Stock Exchange Ltd.Pherojbhoy Jeejeebhoy TowerDalal Street, Mumbai - 400 001.CM Quote : JAGSNPHARM Scrip Code : 507789OUT-COME OF THE MEETING OF BOARD OF DIRECTORS OF JAGSONPAL PHARMACEUTICALS LIMITED HELD ON 14.08.2017Sir, Performance of the 1st Quarter and three months ended 30.06.2017 (Un-audited) was placed before the Board having reviewed by the Audit Committee. The issue was discussed. Approval of Quarterly performance and three months ended 30.06.2017 as approved by the Board of Directors and resolution in this regard was passed with an authority to Managing Director to publish in newspapers and send same to National Stock Exchange of India Limited (NSE) & Bombay Stock Exchange Limited (BSE). Auditors Limited Review statement is enclosed. Cost Audit Report was also approved and taken on record by the Board. Other routine matters were discussed by Board and taken care. Any another matter with the permission. Meeting concluded with vote of thanks, The meetings commence at 11.00 a. m. and concluded at 1.45 p.m. Audit Committee Chairman has been replaced by Mr. Bharat Sinh.Thanking you,Yours faithfully,For JAGSONPAL PHARMACEUTICALS LIMITEDR K KAPOOR COMPLIANCE OFFICER & COMPANY
- 14 Aug · Results
  Financial results for the period ended 30-Jun-2017.
- 14 Aug · Corporate action
  Register of Members and Share Transfer Books of the Company shall remain closed from September 23, 2017 to September 29, 2017 (both days inclusive) for the purpose of Declaration of dividend and annual general meeting.
Jun 2017
- 16 Jun · Results
  Financial results for the period ended 31-Mar-2017.
- 7 Jun · Audit Qualifications/Comments
  Auditors Report given by Statutory Auditors is clean and does not have any qualification or reservation and no figure have been modified / adjusted.
May 2017
- 29 May · Meeting
  Register of Members and Share Transfer Books of the Company shall remain closed from September 26, 2017 to September 29, 2017 (both days inclusive) for the purpose of dividend and Annual General Meeting of the Company scheduled to be held on September 29, 2017.
- 29 May · Dividend
  Board of Directors of the Company at its meeting held on May 28, 2017, has recommended a dividend at the rate of Rs.0.10 per equity share of Rs.5/- each. The dividend, if approved by the shareholders in the ensuing Annual General meeting scheduled to be held on September 29, 2017.
- 29 May · Board meeting
  Outcome of Board Meeting held on May 28, 2017.
- 28 May · Results
  Financial results for the period ended 31-Mar-2017.
- 19 May · Board meeting
  Inter alia to consider and approve the Audited Financial Results of the Company for the year from April 1st, 2016 to March 31, 2017 and consider Dividend,
Apr 2017
Mar 2017
- 24 Mar · Disclosure
  Vide letter dated March 23, 2017 a copy of disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
- 24 Mar · Disclosure
  Vide letter dated March 23, 2017 a copy of disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
Feb 2017
- 15 Feb · Management
  Dr. Surinder Kumar Goyal, Director has resigned from Directorship of the Company w. e. f. February 14, 2017, his resignation has been approved by the Board of Directors in their meeting held on February 14, 2017.
- 14 Feb · Results
  Financial results for the period ended December 31, 2016.
- 14 Feb · Board meeting
  Outcome of Board meeting held on February 14, 2017.
- 3 Feb · Board meeting
  Inter alia to consider and approve the Un-audited Financial Results (provisional) of the Company for the third quarter and nine months ended December 31, 2016.
Nov 2016
- 11 Nov · Results
  Financial results for the period ended 30-Sep-2016.
- 11 Nov · Board meeting
  Outcome of board meeting of the Company held on November 11, 2016
- 2 Nov · Board meeting
  Inter alia to consider and approve the Un-audited Financial Results (provisional) of the Company for the second quarter/ and half year ended September 30, 2016.
Oct 2016
- 1 Oct · Regulation 44(3) of SEBI (LODR), Reg., 2015
  Copy voting results at the Annual General Meeting of the Company held on September 30, 2016 along with a copy of Scrutinizer's Report.
Sep 2016
- 30 Sep · Meeting
  Proceedings of the Annual General Meeting of the Company held on September 30, 2016.
- 14 Sep · Meeting
  Notice of Annual General Meeting to be held on September 30, 2016.
Aug 2016
May 2016
Apr 2016
- 13 Apr · Regulation 44(3) of SEBI (LODR), Reg., 2015
  Details of voting results of the Extra Ordinary General Meeting of the Company pursuant to Regulation 44(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- 12 Apr · Meeting
  Proceeding of Extra Ordinary General Meeting of the Company held on April 12, 2016.
- 9 Apr · Disclosure
  Vide letter dated April 5, 2016 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
Mar 2016
- 18 Mar · Meeting
  Mr. Amit Pathak,As discussed, we are sending txt and pdf file.SPECIAL BUSINESSItem No. 1: Sale of undertaking under Section 180 (1) (a) of the Companies Act, 2013.To consider and if thought fit, to pass with or without modification(s), the following resolution as a Special Resolution:"RESOLVED THAT pursuant to the provisions of section 180(1)(a) and other applicable provisions, if any, of the Companies Act, 2013, and the relevant Rules framed there under (including any statutory modification(s) or re-enactment thereof, for the time being in force), and the enabling provisions in the Memorandum of Association and Articles of Association of the Company, approval and consent of the members of the Company be and is hereby granted to the Board of Directors to sell and transfer the fixed assets including land, Building, Plant & Machinery & other assets at Pantnagar, Uttarakhand, including the identified employees of the Company and certain identified assets of the Company which are specific to the Manufacture, at a fair value which will not be lower than 1.5 times of book value of assets at Pant Nagar plant of the Jagsonpal Pharmaceuticals Limited. Uttarakhand.Item No.2: Approval of related party transaction under Section 188 of the Companies Act, 2013.To consider and if thought fit, to pass with or without modification(s), the following resolution as an Ordinary Resolution:"RESOLVED THAT pursuant to Section 188 and other applicable provisions, if any of the Companies Act, 2013 and relevant Rules made there under (including any statutory modification(s) or re-enactment thereof, for the time being in force) consent of the members be and is hereby accorded to the Board of Directors to enter into an agreement with the buyer Company for effecting the sale and transfer of fixed assets including land, Building, Plant & Machinery & other assets at Pantnagar, Uttarakhand, including certain identified employees of the Company and certain identified assets the Company which are specific to the Manufacture, at a fair value which will not be lower than 1.5 times of the book value of the assets at Pantnagar, Plant."RESOLVED FURTHER that Mr. Rajpal Singh Kochhar (DIN:00059492), Managing Director and or Mr. Sanjiv Kumar Dudeja, Chief Financial Officer, be and are hereby, severally, authorised to do such acts, deeds, things and execute all such documents, undertaking as may be necessary for giving effect to the above resolutions."
Feb 2016
- 17 Feb · Board meeting
  Outcome of the Board Meeting held on February 17, 2016.
- 13 Feb · Board meeting
  Inter-alia, to consider and approve the notice and date for Extra Ordinary General Meeting of the Company.
- 13 Feb · Board meeting
  Outcome of Board Meeting held on February 12, 2016.
- 12 Feb · Results
  Standalone financial results along with the Limited Review Report for the period ended December 31, 2015.
- 4 Feb · Board meeting
  Inter-alia, to consider and approve the Un-audited Financial results of the Company for the third quarter and nine months ended on December 31, 2015 alongwith other items of the agenda.
Jan 2016
- 25 Jan · Board meeting
  Proceedings of the meeting of Board of Directors held on January 25, 2016.
- 21 Jan · Board meeting
  To consider the following:1. To authorize Managing Director and/or Company Secretary to sign, execute and file the new Listing Agreement, pursuant to the amendments, with NSE & BSE and to comply other provisions in relation to the applicable provisions of Companies Act, 2013 as amended upto date. 2 .To explore opportunities, in connection with optimum utilization of Company s assets and analyze the cost comparison / utilization of funds by alternate means pursuant to clause 36 (1) of the listing agreements.3. Any other matter with the permission of Chair

Jagsonpal Pharmaceuticals share news and announcements

Oct 2017

Sep 2017

Aug 2017

Jun 2017

May 2017

Apr 2017

Mar 2017

Feb 2017

Nov 2016

Oct 2016

Sep 2016

Aug 2016

May 2016

Apr 2016

Mar 2016

Feb 2016

Jan 2016